Pay in 4 interest-free payments of $6.08 Learn more
Ships within 48 hours · Estimated delivery Sep 30 - Oct 5
Don't compromise here
Among the other GLP1RA, semaglutide has superior evidence in terms of weight loss, with an average weight loss of 4.5 to 6.5 kg, as seen in the SUSTAIN trials at a dose of 1 mg
GLP-1 receptor agonists are typically added to your type 2 diabetes treatment if you: Cant take metformin Still have high blood sugar levels or A1C levels while on other medications Are having complications related to: chronic kidney disease (CKD) heart failure atherosclerosis These medications can help reduce the risk of heart attack, stroke, or death in adults with type 2 diabetes mellitus and known heart disease
Individuals, health practitioners and businesses must ensure they are meeting all their obligations under Commonwealth and State legislation, in addition to relevant regulatory requirements and professional practice standards, including AHPRA and the Pharmacy Board of Australia
US$ 22.94
US$ 21.50
US$ 28.84
US$ 22.51
US$ 24.88
US$ 28.51
